Clinical Trials Directory

Trials / Completed

CompletedNCT03940118

Safety of Mechanical Insufflation-exsufflation and Hypertonic Saline

A Randomized Study on the Safety and Tolerability of Mechanical Insufflation-exsufflation and Hypertonic Saline With Hyaluronic Acid for Suctioning of Respiratory Tract Secretions in Patients With Artificial Airway

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Hospital San Carlos, Madrid · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Conventional catheter suctioning of respiratory tract secretions is a mandatory procedure in intubated patients. Poor tolerance, pain and other, sometimes severe, lung and cardiovascular complications may occur during suctioning. Mechanical insufflation-exsufflation (MIE), coupled with hypertonic saline (HS), may improve efficacy airway clearance and reduce risk of the maneuver. However, safety of MIE and HS in intubated patients have not been studied appropriately, which justifies a randomized evaluation compared to conventional secretion suctioning.

Detailed description

Secretion suctioning (SS) in patients with artificial airway is a mandatory procedure, although occasionally painful, not tolerated and even causing traumatic injury to the respiratory mucosa. Mechanical insufflation-exsufflation (MIE) and nebulized hypertonic saline with hyaluronic acid (HS-HA) have shown efficacy and safety in patients with chronic neuromuscular and pulmonary diseases, achieving aspiration and fluidification of respiratory secretions, respectively, as well as good tolerance. Only anecdotal experience about the safety of MIE and HS-HA in critically ill patients with artificial airway and mechanical ventilation is available. Background: Both MIE and HS-HA facilitate the drainage of secretions from the distal airway (compared to conventional catheter suctioning, the effect of which is supposed to be limited to the trachea) Both measures may prove to be efficacious in the prevention (through airway clearance of secretions) and concomitant treatment (reduction of inoculum or "draining the lung") of lower respiratory tract infections (tracheobronchitis and pneumonia).

Conditions

Interventions

TypeNameDescription
DEVICECatheter secretion suctioningCatheter secretion suctioning with prior nebulization of hypertonic saline
COMBINATION_PRODUCTSecretion suctioning + hypertonic salineCatheter secretion suctioning with prior nebulization of hypertonic saline
DEVICEIns-exsufflationApplication of a mechanical insufflation-exsufflation device for respiratory tract secretion suctioning
COMBINATION_PRODUCTIns-exsufflation + Hypertonic salineApplication of a mechanical insufflation-exsufflation device for respiratory tract secretion suctioning

Timeline

Start date
2018-06-01
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2019-05-07
Last updated
2019-05-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03940118. Inclusion in this directory is not an endorsement.